ACCESSION: MSBNK-SMB_Measured-HSA015P0249004
RECORD_TITLE: Characterized; Glutamylthreonine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 21
COMMENT: RAW_SPEC {'EL20_pos_1305': {'bp': 66383.0, 'sum': 337562.0}, 'EL19_pos_1324': {'bp': 60317.0, 'sum': 375120.0}, 'EL18_pos_1313': {'bp': 52572.0, 'sum': 326808.0}, 'EL21_pos_1306': {'bp': 49009.0, 'sum': 307119.0}, 'EL16_pos_1311': {'bp': 48997.0, 'sum': 264143.0}, 'EL08_pos_1316': {'bp': 48169.0, 'sum': 281067.0}, 'EL17_pos_1305': {'bp': 47565.0, 'sum': 321617.0}, 'EL24_pos_1323': {'bp': 42131.0, 'sum': 234830.0}, 'EL06_pos_1318': {'bp': 41902.0, 'sum': 240589.0}, 'EL13_pos_1316': {'bp': 40120.0, 'sum': 252787.0}, 'EL09_pos_1319': {'bp': 38668.0, 'sum': 280617.0}, 'EL23_pos_1319': {'bp': 37838.0, 'sum': 209289.0}, 'EL05_pos_1318': {'bp': 37009.0, 'sum': 259790.0}, 'EL01_pos_1319': {'bp': 36893.0, 'sum': 243880.0}, 'EL02_pos_1322': {'bp': 35140.0, 'sum': 270938.0}, 'EL22_pos_1319': {'bp': 34586.0, 'sum': 236922.0}, 'EL14_pos_1328': {'bp': 32721.0, 'sum': 251160.0}, 'EL07_pos_1323': {'bp': 32416.0, 'sum': 239415.0}, 'EL04_pos_1329': {'bp': 31013.0, 'sum': 206299.0}, 'EL10_pos_1319': {'bp': 28006.0, 'sum': 196849.0}, 'EL11_pos_1325': {'bp': 26178.0, 'sum': 199048.0}}
COMMENT: RETENTION_TIME_STDEV 0.009
COMMENT: PRECURSOR_M/Z_RAW 249.108219
COMMENT: PRECURSOR_M/Z_STDEV 0.000098
COMMENT: PRECURSOR_IN_MS1 mz 249.108146; int 61.962; delta(ppm) 1.182261
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.121; C9H16N2O6; [M+H]+; delta(ppm) 0.120919
COMMENT: PROPOSED_MF MS-FINDER 3.790; C9H16N2O6; [M+H]+; delta(ppm) 0.117663
COMMENT: PROPOSED_MF MS-FINDER 1.941; C11H21O2PS; [M+H]+; delta(ppm) 3.531227
COMMENT: PROPOSED_MF MS-FINDER 1.847; C10H20N2OS2; [M+H]+; delta(ppm) -3.370841
COMMENT: PROPOSED_MF SIRIUS5_Sirius 47.074; C9H16N2O6; [M+H]+; delta(ppm) 0.117663
COMMENT: PROPOSED_MF SIRIUS5_Sirius 30.160; C10H12N6O2; [M+H]+; delta(ppm) -5.251118
COMMENT: PROPOSED_MF SIRIUS5_Sirius 24.120; C15H12BNO2; [M+H]+; delta(ppm) 41883.353746
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.609; C12H15F3O2; [M+H]+; delta(ppm) -6.214750
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H16N2O6; [M+H]+; delta(ppm) 0.117663
COMMENT: PROPOSED_MF SIRIUS6_Sirius 67.827; C9H16N2O6; [M+H]+; delta(ppm) 0.117663
COMMENT: PROPOSED_MF SIRIUS6_Sirius 48.718; C10H12N6O2; [M+H]+; delta(ppm) -5.251118
COMMENT: PROPOSED_MF SIRIUS6_Sirius 47.577; C7H14N5O5; [M+H]+; delta(ppm) 5.507576
COMMENT: PROPOSED_MF SIRIUS6_Sirius 45.148; C7H15F3N2O4; [M+H]+; delta(ppm) 9.933884
COMMENT: PROPOSED_MF SIRIUS6_Sirius 41.295; C7H13FN6O3; [M+H]+; delta(ppm) -9.838028
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.452; C15H12BNO2; [M+H]+; delta(ppm) 41883.353746
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.747; C6H15N7O2P; [M+H]+; delta(ppm) -6.491942
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.587; C10H17FN2O2S; [M+H]+; delta(ppm) 5.574987
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.633; C10H20N2OS2; [M+H]+; delta(ppm) -3.370841
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.844; C5H12F4N6O; [M+H]+; delta(ppm) -0.022003
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H16N2O6; [M+H]+; delta(ppm) 0.117663
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.455; JSIQVRIXMINMTA-JWBGBCPUNA-N; [M+H]+; C[C@@H](O)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.250; GWNXFCYUJXASDX-JWBGBCPUNA-N; [M+H]+; C[C@@H](O)[C@H](NC(=O)CC[C@H](N)C(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.616; RTZNBQDMLJXMJW-UHFFFAOYSA-N; [M+H]+; CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.333; CLJMUGBMMVBGHE-UHFFFAOYSA-N; [M+H]+; O=C(O)C1NC2N(C1)C(CO)C(O)C(O)C2O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.231; UCKYOOZPSJFJIZ-UHFFFAOYSA-N; [M+H]+; C1CN(C(=O)NC1O)C2C(C(C(O2)CO)O)O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.512; GWNXFCYUJXASDX-JWBGBCPUNA-N; [M+H]+; gamma-Glutamylthreonine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.370; JSIQVRIXMINMTA-JWBGBCPUNA-N; [M+H]+; Glutamylthreonine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.181; UCKYOOZPSJFJIZ-UHFFFAOYSA-N; [M+H]+; 1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.112; CLJMUGBMMVBGHE-UHFFFAOYSA-N; [M+H]+; 6,7,8-trihydroxy-5-(hydroxymethyl)-octahydroimidazo[1,2-a]pyridine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.060; XINFXVVRMYBFMI-YFKPBYRVSA-N; [M+H]+; Nz-(Dicarboxymethyl)Lysine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.023; KXQRAPMNPUXYGT-QTOHJERDNA-N; [M+H]+; Malioxamycin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.997; RTZNBQDMLJXMJW-UHFFFAOYSA-N; [M+H]+; 2-[2-[bis(carboxymethyl)amino]ethyl-methylamino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; GWNXFCYUJXASDX-JWBGBCPUNA-N; [M+H]+; gamma-Glutamylthreonine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.993; JSIQVRIXMINMTA-JWBGBCPUNA-N; [M+H]+; Glutamylthreonine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.992; XINFXVVRMYBFMI-YFKPBYRVSA-N; [M+H]+; Nz-(Dicarboxymethyl)Lysine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.941; CLJMUGBMMVBGHE-UHFFFAOYSA-N; [M+H]+; 6,7,8-trihydroxy-5-(hydroxymethyl)-octahydroimidazo[1,2-a]pyridine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.902; UCKYOOZPSJFJIZ-UHFFFAOYSA-N; [M+H]+; 1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.864; RTZNBQDMLJXMJW-UHFFFAOYSA-N; [M+H]+; 2-[2-[bis(carboxymethyl)amino]ethyl-methylamino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.662; KXQRAPMNPUXYGT-QTOHJERDNA-N; [M+H]+; Malioxamycin
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.913; UCKYOOZPSJFJIZ-XVKVHKPRSA-N; [M+H]+; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.193; JSIQVRIXMINMTA-ZDLURKLDSA-N; [M+H]+; (4S)-4-amino-5-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.177; BECPPKYKPSRKCP-ZDLURKLDSA-N; [M+H]+; (2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]pentanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; GWNXFCYUJXASDX-ZDLURKLDSA-N; [M+H]+; (2S)-2-amino-5-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.876; KXQRAPMNPUXYGT-VDTYLAMSSA-N; [M+H]+; (2R)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]oxybutanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -2.404; JSIQVRIXMINMTA; [M+H]+; L-alpha-glutamyl-L-threonine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -46.164; GWNXFCYUJXASDX; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -101.318; BECPPKYKPSRKCP; [M+H]+; Threoninyl-Glutamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.528; VTEXNADNTYNYRI; [M+H]+; N-[(3s)-3-Amino-3-Carboxypropyl]-L-Glutamic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -215.310; XINFXVVRMYBFMI; [M+H]+; Nz-(Dicarboxymethyl)Lysine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -309.680; YWTXUGAXXGHUOR; [M+H]+; (4r)-4-{3-[hydroxy(Methyl)amino]-3-Oxopropyl}-L-Glutamic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -312.804; KXQRAPMNPUXYGT; [M+H]+; Malioxamycin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -445.209; UCKYOOZPSJFJIZ; [M+H]+; 3,4,5, 6-Tetrahydrouridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -467.817; CLJMUGBMMVBGHE; [M+H]+; Carboxylate-Substituted Glucoimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.687; JSIQVRIXMINMTA; [M+H]+; L-alpha-glutamyl-L-threonine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -42.114; JSIQVRIXMINMTA; [M+H]+; 4-amino-4-[(1-carboxy-2-hydroxypropyl)carbamoyl]butanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -139.301; GWNXFCYUJXASDX; [M+H]+; Gamma-Glutamylthreonine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -184.272; BECPPKYKPSRKCP; [M+H]+; (2S)-2-[[(2S)-2-amino-3-hydroxybutanoyl]amino]pentanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -261.526; VTEXNADNTYNYRI; [M+H]+; N-[(3s)-3-Amino-3-Carboxypropyl]-L-Glutamic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -331.736; YWTXUGAXXGHUOR; [M+H]+; [(1S,3R)-1,3-dicarboxy-6-[hydroxy(methyl)amino]-6-oxohexyl]azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -342.782; RTZNBQDMLJXMJW; [M+H]+; N-{2-[Bis(carboxymethyl)amino]ethyl}-N-methylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -361.112; XINFXVVRMYBFMI; [M+H]+; Nz-(Dicarboxymethyl)Lysine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -368.322; KXQRAPMNPUXYGT; [M+H]+; Malioxamycin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -460.226; HLTQHEUEASZSMZ; [M+H]+; (2S,3S,4S,6S)-3-amino-2-[(1S,2S)-1-amino-2-hydroxypropyl]-4-hydroxy-7-oxa-1-oxoniabicyclo[4.1.0]heptane-6-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -496.111; JJSHPKVARZQPOG; [M+H]+; (1R,3S,4S,5R,6S)-4-amino-3-[(1S,2S)-1-amino-2-hydroxypropyl]-5-hydroxy-2,7-dioxabicyclo[4.1.0]heptane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.978; JSIQVRIXMINMTA; [M+H]+; 4-amino-4-[(1-carboxy-2-hydroxypropyl)carbamoyl]butanoic acid
COMMENT: CONFIDENCE Level 3: Tentative candidate, Glutamylthreonine, JSIQVRIXMINMTA-ZDLURKLDSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (2); This structural isomer was suggested from the biological context HMDB HMDB0028829;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C9H16N2O6
CH$EXACT_MASS: 248.100836
CH$SMILES: C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O
CH$IUPAC: InChI=1S/C9H16N2O6/c1-4(12)7(9(16)17)11-8(15)5(10)2-3-6(13)14/h4-5,7,12H,2-3,10H2,1H3,(H,11,15)(H,13,14)(H,16,17)/t4-,5+,7+/m1/s1
CH$NAME: Glutamylthreonine
CH$NAME: Glutamylthreonine
CH$NAME: (4S)-4-amino-5-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-5-oxopentanoic acid
CH$LINK: INCHIKEY JSIQVRIXMINMTA-ZDLURKLDSA-N
CH$LINK: PUBCHEM CID:6998031
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.120
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 249.108142
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00e9-9710000000-2ea4e18dc75d4bfe4c42
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0497464 341.7337 56.050459 0.6244 42.84 0.8766 21 f{C3H6N1}/4.83ppm,p-C6H11N1O6
  57.0700682 100.5813 57.070785 1.1214 32.49 0.0000 17 f{C4H9}/3.36ppm,p-C5H8N2O6
  74.0601501 775.9272 74.060891 0.4861 81.04 0.9117 21 f{C3H8N1O1}/1.48ppm,p-C6H9N1O5
  76.0215908 107.1940 76.022329 1.2628 44.48 -0.1941 16 ?
  81.0699130 78.6297 81.070639 0.9745 21.71 0.0088 16 f{C6H9}/0.45ppm,p-C3H8N2O6
  84.0444492 941.4043 84.045165 0.4283 68.12 0.9351 21 f{C4H6N1O1}/0.70ppm,p-C5H11N1O5
  102.0549425 507.4329 102.055536 0.9113 39.03 1.0000 21 f{C4H8N1O2}/-0.12ppm,p-C5H9N1O4
  120.0655518 999.0000 120.065990 0.4997 22.02 0.9740 21 f{C4H10N1O3}/0.27ppm,p-C5H7N1O3
  130.0499165 181.7612 130.050251 1.1457 25.17 0.8897 17 f{C5H8N1O3}/0.36ppm,p-C4H9N1O3
  140.0703819 96.5749 140.070656 1.3779 21.55 0.6296 20 f{C7H10N1O2}/-1.59ppm,p-C2H7N1O4
  174.0761572 100.0739 174.076526 1.1202 42.39 0.0147 16 f{C7H12N1O4}/0.42ppm,p-C2H5N1O2
  186.0763960 111.5248 186.076801 1.8326 26.81 0.7964 15 f{C8H12N1O4}/1.68ppm,p-C1H5N1O2
  231.0974864 227.9549 231.097848 1.3977 36.70 0.8535 18 f{C9H15N2O5}/-0.27ppm,p-H2O1
  251.1635835 127.7965 251.163953 1.3378 58.43 -0.2714 18 ?
PK$NUM_PEAK: 14
PK$PEAK: m/z int. rel.int.
  56.049746 341.73 341
  57.070068 100.58 100
  74.060150 775.93 775
  76.021591 107.19 107
  81.069913 78.63 78
  84.044449 941.40 941
  102.054942 507.43 507
  120.065552 999.00 999
  130.049916 181.76 181
  140.070382 96.57 96
  174.076157 100.07 100
  186.076396 111.52 111
  231.097486 227.95 227
  251.163583 127.80 127
//
